Literature DB >> 15616479

The role of estrogen and estrogen receptorbeta in choroidal neovascularization.

Mai Tanemura1, Noriko Miyamoto, Michiko Mandai, Hiroshi Kamizuru, Sotaro Ooto, Tsutomu Yasukawa, Masayo Takahashi, Yoshihito Honda.   

Abstract

PURPOSE: Choroidal neovascularization (CNV) under the age of 50 is more often observed in women than in men. The effects of 17beta-estradiol (E2) on choroidal neovascularization development were investigated both in animal models and cultured cells to see if estrogen receptors (ERs) are involved in the process.
METHODS: CNV was induced by fundus laser photocoagulation in adult male and female rats. The degree of CNV development was scored and compared between them. Gene expression levels of VEGF receptor 2 (VEGFR2) and ERs after photocoagulation were compared between genders using real time PCR. CNV formation and the gene expressions were also examined in ovariectomized females with and without E2 treatment. The roles of ERs were studied by overexpressing them in human umbilical vein endothelial cells (HUVECs). The localization of estrogen receptorbeta (ERbeta) and VEGFR2 in CNV were studied immunohistochemically.
RESULTS: CNV scores were significantly higher in females than in males 14 and 21 days after photocoagulation (<0.05). VEGFR2 and ERbeta gene levels were increased more in females than in males on day 7 (3.4 fold compared to 1.8 fold) and on day 3 (5.8 fold compared to 2.3 fold) after photocoagulation, respectively. Both ERbeta and VEGFR2 gene expressions were additively enhanced by photocoagulation and E2 treatment in ovariectomized females. E2 significantly enhanced VEGFR2 gene expression and cell proliferation in HUVECs overexpressing ERbeta. ERbeta and VEGFR2 are well co-localized in CNV tissue.
CONCLUSIONS: Estrogen may promote CNV development by increasing VEGFR2 gene expression via ERbeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15616479

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  9 in total

1.  Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.

Authors:  Iqbal Ahmad; Sudha Balasubramanian; Carolina B Del Debbio; Sowmya Parameswaran; Allen R Katz; Carol Toris; Robert N Fariss
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

2.  Gastric cancer drug trials - are women second class citizens?

Authors:  Lishi Wang; Yan Jiao; Yun Jiao; Yanhong Cao; Weikuan Gu
Journal:  Nat Rev Clin Oncol       Date:  2014-06-03       Impact factor: 66.675

3.  Risk factor analysis of 167 patients with high myopia.

Authors:  Ya Mo; Ming-Fang Wang; Lu-Lu Zhou
Journal:  Int J Ophthalmol       Date:  2010-03-18       Impact factor: 1.779

Review 4.  Vascular endothelial growth factor receptor-2 in breast cancer.

Authors:  Shanchun Guo; Laronna S Colbert; Miles Fuller; Yuanyuan Zhang; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-05-11

5.  Bilateral consecutive choroidal neovascularization in Best vitelliform macular dystrophy.

Authors:  Sandra Hoyek; Lisa Y Lin; Lindsay Klofas Kozek; Efren Gonzalez; Farrah Rajabi; Nimesh A Patel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-05

6.  Drug delivery to posterior intraocular tissues: third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.

Authors:  Henry F Edelhauser; Jeffrey H Boatright; John M Nickerson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

7.  Severe macular edema in patients with juvenile idiopathic arthritis-related uveitis.

Authors:  Maria Pia Paroli; Claudia Fabiani; Giovanni Spinucci; Irene Abicca; Alfredo Sapia; Leopoldo Spadea
Journal:  Case Rep Ophthalmol Med       Date:  2013-08-19

Review 8.  Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases.

Authors:  Pei-Li Yao; Jeremy Peavey; Goldis Malek
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

9.  Inhibition of laser induced rats choroidal neovascularization by intravitreous injection of sEphB4-HSA.

Authors:  Shikun He; Sha Ouyang; Xiaohua Li; Binyun Ma
Journal:  Ann Transl Med       Date:  2021-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.